# Degarelix Before Radical Prostatectomy

> **NCT01852864** · EARLY_PHASE1 · UNKNOWN · sponsor: **University of Cambridge** · enrollment: 40 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 240mg degarelix s.c. injection

## Key facts

- **NCT ID:** NCT01852864
- **Lead sponsor:** University of Cambridge
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2015-07
- **Final completion:** 2015-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01852864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01852864, "Degarelix Before Radical Prostatectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01852864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*